Previous studies have indicated high NF-κB expression in triple-negative breast cancer, where it promotes tumor proliferation and migration by binding to the FOXC1 promoter region, thereby increasing FOXC1 expression [30]. The gene discussed is NFKB1; the disease is neoplasm.